Basics ADiTx Therapeutics, Inc. IPO Date: June 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.46M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 5.90% Avg Daily Range (30 D): $0.03 | 4.88% Avg Daily Range (90 D): $0.04 | 4.32% Institutional Daily Volume Avg Daily Volume: 5.58M Avg Daily Volume (30 D): 1.43M Avg Daily Volume (90 D): .98M Trade Size Avg Trade Size (Sh.): 646 Avg Trade Size (Sh.) (30 D): 270 Avg Trade Size (Sh.) (90 D): 232 Institutional Trades Total Inst.Trades: 23 Avg Inst. Trade: $.7M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.51M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.99M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Oct 20, 2025 @ 8:19 PM Evofem Announces Voting Results from Special Meeti... Source: Prnewswire Sep 11, 2025 @ 1:18 PM Evofem's "Say Vagina" Campaign Generates More than... Source: Prnewswire Sep 9, 2025 @ 1:28 PM Evofem Anticipates Approval of Merger with Aditxt ... Source: Prnewswire Aug 19, 2025 @ 1:39 PM FDA Orange Book Lists New U.S. Patent for SOLOSEC,... Source: Prnewswire Aug 14, 2025 @ 1:07 PM Evofem Revenue Jumps 16 Percent in Q2 Source: Jesterai Financials   TTM Q2 2025 Q1 2025 Basic EPS $188.56 $-3.45 $-8.12 Diluted EPS $188.56 $-3.45 $-8.12 Revenue $ .01M $ M $ M Gross Profit $ -.53M $ M $ M Net Income / Loss $ -25.88M $ -7.4M $ -5.95M Operating Income / Loss $ -22.11M $ -6.15M $ -5.61M Cost of Revenue $ .54M $ M $ M Net Cash Flow $ .23M $ -.51M $ M PE Ratio 0.00     Splits Mar 17, 2025:   1:250 Oct 02, 2024:   1:40 Aug 18, 2023:   1:40 Sep 14, 2022:   1:50